Director/PDMR Shareholding

By

Regulatory News | 14 May, 2020

Updated : 12:36

RNS Number : 9429M
Medica Group PLC
14 May 2020
 

 

Medica Group PLC

 

Director / PDMR Shareholding

 

Medica Group PLC ("Company") announces that on 14 May 2020 an option was granted under the Medica Group PLC Sharesave Scheme to a PDMR.

 

The option was granted with an exercise price of 100p per share, and is exercisable after the maturity of an associated three year savings contract.

 

The notification set out below is provided in accordance with the requirements of the EU Market Abuse Regulation.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

a)

 

Name

 

 Marc O'Brien

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Technical Officer

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Medica Group PLC

b)

 

LEI

 

213800B8XE5FUSZF5Z16

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 0.2p each in the capital of the Company ("Shares")



Identification code




b)

 

Nature of the transaction

 

 

Grant of an option to acquire Shares

c)

 

Price(s) and volume(s)

 

Price(s)

Volume(s)

100p

18,000





d)

 

Aggregated information

N/A



- Aggregated volume




- Price




e)

 

Date of the transaction

 

 

14th May 2020

f)

 

Place of the transaction

 

 

Outside of trading venue

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHKKQBBDBKDAPD

Last news